| Dr Jonas A Reid, MD | |
|
2300 S 1st St, Champaign, IL 61820-7661 | |
| (217) 383-9400 | |
| (217) 383-9694 |
| Full Name | Dr Jonas A Reid |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 2300 S 1st St, Champaign, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689086266 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Carle Foundation Hospital | Urbana, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carle Health Care Incorporated | 3577515774 | 808 |
News Archive
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale researchers published July 27 in the journal Nature.
Chronic infection with the hepatitis B virus (HBV) is responsible for an enormous burden of disease throughout the world, including up to half of all cases of cirrhosis, end-stage liver disease, and hepatocellular carcinoma, a cancer of the liver.
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
› Verified 7 days ago
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale researchers published July 27 in the journal Nature.
Chronic infection with the hepatitis B virus (HBV) is responsible for an enormous burden of disease throughout the world, including up to half of all cases of cirrhosis, end-stage liver disease, and hepatocellular carcinoma, a cancer of the liver.
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonas A Reid, MD 611 W Park St, Fapc, Urbana, IL 61801 Ph: () - | Dr Jonas A Reid, MD 2300 S 1st St, Champaign, IL 61820-7661 Ph: (217) 383-9400 |
News Archive
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale researchers published July 27 in the journal Nature.
Chronic infection with the hepatitis B virus (HBV) is responsible for an enormous burden of disease throughout the world, including up to half of all cases of cirrhosis, end-stage liver disease, and hepatocellular carcinoma, a cancer of the liver.
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
› Verified 7 days ago
Dr. Michael C Moran, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1802 S. Mattis Avenue, Orthopedics, Champaign, IL 61821 Phone: 217-383-7676 Fax: 217-383-4910 | |
Kenneth J Dols, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1802 S. Mattis Avenue, Orthopedics, Champaign, IL 61821 Phone: 217-383-7676 Fax: 217-383-4910 | |
Robert P Cusick, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1237 | |
Morgan Leigh Moon, MD, PHD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1237 | |
Mark E Palermo, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1802 S Mattis Ave, Ortho, Champaign, IL 61821 Phone: 217-383-3260 Fax: 217-383-4459 | |
Dr. David R Zeman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 S 1st St, Champaign, IL 61820 Phone: 217-383-9400 Fax: 217-383-9691 | |
Robert A Bane, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 S 1st St, Champaign, IL 61820 Phone: 217-383-9400 |